RocketTickers

TG Therapeutics Announces Positive Topline Results from the UNIT

Long
NASDAQ:TGTX   TG Therapeutics, Inc.
TGTX: TG Therapeutics, Inc.
2020-05-05 07:00:10
TG Therapeutics Announces Positive Topline Results from the UNITY-CLL Phase 3 Study Evaluating the Combination of Umbralisib and Ublituximab (U2) for the Treatment of Patients with Chronic Lymphocytic Leukemia

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.